Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0Q6H
DateHeureSourceTitreSymboleSociété
12/12/202415h07UK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
05/12/202409h00UK RegulatoryHofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacityLSE:0Q6HHofseth Biocare Asa
08/11/202408h15UK RegulatoryHofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
22/10/202410h55UK RegulatoryHofseth Biocare ASA: CFO RESIGNATIONLSE:0Q6HHofseth Biocare Asa
08/10/202408h45UK RegulatoryHofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENTLSE:0Q6HHofseth Biocare Asa
23/08/202408h00UK RegulatoryHofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
14/08/202413h09UK RegulatoryHofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERYLSE:0Q6HHofseth Biocare Asa
02/07/202409h00UK RegulatoryHofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.LSE:0Q6HHofseth Biocare Asa
11/06/202409h00UK RegulatoryHofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHYLSE:0Q6HHofseth Biocare Asa
16/05/202408h00UK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
10/05/202414h30UK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
19/04/202413h00UK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
19/04/202408h00UK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
05/04/202418h08UK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
21/03/202410h40UK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
14/03/202412h12UK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
09/02/202408h00UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
06/02/202415h56UK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H